PR Newswire•March 12, 2019 LAKEWOOD, CO, March 12, 2019 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), today reported its financial results for the year ended December 31, 2018. The Company’s Annual Report on Form 10-K has been filed with the U.S. Securities and Exchange Commission (“SEC”), and may…
DetailsDenver, Colorado – June 28, 2018 Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading producer of uranium and vanadium in the United States, is pleased to announce that it recently strengthened its cash position and currently has sufficient existing cash on hand to allow the Company the ability…
DetailsLOS ANGELES, May 23, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 8th annual LD Micro Invitational on Monday, June 4th at 4 PM PT/ 7 PM ET at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. CEO Rob…
DetailsGlobeNewswire•June 5, 2018 LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that CEO Rob Davidson will be presenting at the O’Cannabiz Conference & Expo on June 9 at 2:50 PM ET in Toronto, Canada. Davidson will discuss “Maximizing and Understanding the Benefits of…
DetailsGlobeNewswire•May 30, 2019 LOS ANGELES, May 30, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 9th Annual LD Micro Invitational on Wednesday, June 5th at 11:40 a.m. PT at the Luxe Sunset Boulevard Hotel in Los Angeles. The conference will…
DetailsGlobeNewswire•December 5, 2019 CURE CEO to discuss company’s expanded technology platform and pharmaceutical pipeline LOS ANGELES, Dec. 05, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD Micro Main Event on Wednesday, December 11 at 9:45 AM PST/…
DetailsGlobeNewswire•April 30, 2019 CURE CEO to discuss expanded product pipeline and company’s continued execution into cannabinoid market. LAS VEGAS, April 30, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it will be presenting at the Planet MicroCap Showcase at 8:30 a.m. on Wednesday, May 1, 2019…
DetailsGlobeNewswire•April 1, 2019 OXNARD, Calif., April 01, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR) (“CURE”), an innovative drug delivery and development company, today announced that it has agreed to acquire Chemistry Holdings Inc. (“Chemistry Holdings”, “CH”), a formulation technology company that is developing innovative delivery systems for a variety of industries, in an all-stock transaction.…
Details